Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 139 publications
Azacitidine-Venetoclax or Induction Chemotherapy for Acute Myeloid Leukemia.
Journal: The New England journal of medicine
Published: September 02, 2026
Treatment of myeloproliferative neoplasms: Exploring new horizons of who and when to cytoreduce in patients with polycythemia vera and essential thrombocytosis.
Journal: Seminars in hematology
Published: May 05, 2026
Between the classic hit and the modern sequel: transition dosing between peginterferon alfa-2a and ropeginterferon alfa-2b for myeloproliferative neoplasms.
Journal: Annals of hematology
Published: April 27, 2026
Cardiovascular complications in patients with myeloproliferative neoplasms: What hematologists need to know.
Journal: Seminars in hematology
Published: March 31, 2026
Clinical features and outcomes of MPN with concurrent MPL and JAK2/CALR Mutations.
Journal: Blood neoplasia
Published: March 09, 2026
Ruxolitinib and heart failure outcomes among patients with myelofibrosis.
Journal: Leukemia & lymphoma
Published: March 05, 2026
Impact of echocardiographic hemodynamics on outcomes among patients with polycythemia vera or essential thrombocythemia.
Journal: Cardio-oncology (London, England)
Published: January 23, 2026
Clinical outcomes of combination treatment with FMS-like tyrosine kinase 3 (FLT3) and isocitrate dehydrogenase 1/2 (IDH1/2) inhibitors in patients with acute myeloid leukaemia.
Journal: British journal of haematology
Published: December 08, 2025
Risk factors associated with high probability of pulmonary hypertension in patients with myeloproliferative neoplasms.
Journal: International journal of hematology
Published: December 02, 2025
Last Updated: 09/26/2026